HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert Krempien Selected Research

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders)

8/2008Leukocyte trafficking in a mouse model for leukocyte adhesion deficiency II/congenital disorder of glycosylation IIc.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert Krempien Research Topics

Disease

16Neoplasms (Cancer)
07/2020 - 07/2003
9Neoplasm Metastasis (Metastasis)
11/2019 - 09/2003
7Sarcoma (Soft Tissue Sarcoma)
12/2018 - 07/2006
6Pancreatic Neoplasms (Pancreatic Cancer)
05/2022 - 04/2009
4Carcinoma (Carcinomatosis)
11/2010 - 07/2006
3Breast Neoplasms (Breast Cancer)
06/2020 - 11/2002
3Rectal Neoplasms (Rectal Cancer)
12/2012 - 11/2006
2Adenocarcinoma
05/2022 - 01/2021
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2010 - 07/2006
2Non-Hodgkin Lymphoma (Lymphosarcoma)
05/2008 - 01/2007
2Neointima
01/2007 - 11/2006
2Hyperplasia
11/2006 - 03/2006
1Chronic Disease (Chronic Diseases)
06/2020
1Fatigue
06/2020
1Renal Cell Carcinoma (Grawitz Tumor)
11/2017
1Lung Diseases (Lung Disease)
01/2017
1Glioma (Gliomas)
11/2010
1Infections
11/2010
1Pain (Aches)
08/2010
1Aggressive Fibromatosis (Desmoid)
03/2010
1Pneumonia (Pneumonitis)
03/2010
1Esophageal Neoplasms (Esophageal Cancer)
07/2009
1Vascular Calcification
12/2008
1Atherosclerosis
12/2008
1Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders)
08/2008
1Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
05/2008
1Keloid
09/2007
1Neurotoxicity Syndromes (Toxic Encephalopathy)
09/2007
1Congenital Abnormalities (Deformity)
08/2007
1Merkel Cell Carcinoma
05/2007
1Necrosis
01/2007
1Orbital lymphoma
01/2007
1Inflammation (Inflammations)
01/2007
1Vascular System Injuries
01/2007
1Vascular Remodeling
11/2006
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
07/2006
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
07/2006
1Glioblastoma (Glioblastoma Multiforme)
07/2006
1Radiation Fibrosis Syndrome (Radiation Fibrosis)
03/2006
1Coronary Artery Disease (Coronary Atherosclerosis)
03/2006
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2006
1Pathologic Constriction (Stenosis)
01/2006
1Hypercalcemia (Milk Alkali Syndrome)
04/2005
1Bone Diseases (Bone Disease)
04/2005
1Ureteral Obstruction
07/2003
1Hydronephrosis
07/2003
1Prostatic Neoplasms (Prostate Cancer)
07/2003

Drug/Important Bio-Agent (IBA)

3Pharmaceutical PreparationsIBA
03/2010 - 01/2005
2Cetuximab (Erbitux)FDA Link
05/2022 - 11/2010
2ErbB Receptors (EGF Receptor)IBA
05/2022 - 11/2010
2LigandsIBA
05/2022 - 08/2008
2Peroxynitrous Acid (Peroxynitrite)IBA
01/2007 - 11/2006
2Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2007 - 11/2006
2Imatinib Mesylate (Gleevec)FDA Link
07/2006 - 03/2006
2Diphosphonates (Bisphosphonates)IBA
04/2005 - 09/2003
1GemcitabineFDA Link
05/2022
1Biological ProductsIBA
11/2019
1Fluorouracil (Carac)FDA LinkGeneric
11/2010
1PlatinumIBA
11/2010
1Carboplatin (JM8)FDA LinkGeneric
11/2010
1Therapeutic UsesIBA
11/2010
1LDL Receptors (LDL Receptor)IBA
12/2008
1GlucocorticoidsIBA
12/2008
1Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
12/2008
1Guanosine Diphosphate Fucose (GDP Fucose)IBA
08/2008
1SelectinsIBA
08/2008
1Cytostatic AgentsIBA
09/2007
1Cisplatin (Platino)FDA LinkGeneric
09/2007
13-nitrotyrosineIBA
01/2007
1Poly Adenosine Diphosphate RiboseIBA
01/2007
1Apoptosis Inducing FactorIBA
01/2007
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
03/2006
1Proteins (Proteins, Gene)FDA Link
01/2005
1AntigensIBA
01/2005
1VaccinesIBA
01/2005
1matrigelIBA
07/2003
1Angiogenesis InhibitorsIBA
07/2003
1orantinib (SU6668)IBA
07/2003
1Semaxinib (SU5416)IBA
07/2003
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
07/2003
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
07/2003

Therapy/Procedure

36Radiotherapy
05/2022 - 07/2003
14Therapeutics
05/2022 - 11/2002
8Drug Therapy (Chemotherapy)
01/2021 - 01/2005
4Chemoradiotherapy
11/2019 - 09/2007
3Combined Modality Therapy
07/2020 - 03/2010
3Brachytherapy
03/2006 - 11/2002
2Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
08/2010 - 02/2004
2Endarterectomy (Thromboendarterectomy)
11/2006 - 03/2006
1Segmental Mastectomy (Lumpectomy)
06/2020
1Re-Irradiation
08/2010
1Operative Surgical Procedures
08/2007
1Catheters
02/2006
1Immunotherapy
01/2005